Pure-play specialty pharma CDMO making biologics, drug-device combos, sterile injectables and softgel capsules for global pharma clients.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 2 | 3 | 4 | 4 | 11 | 11 | 11 |
| Reserves | 774 | 1.0k | 781 | 392 | 5.9k | 5.9k | 5.8k |
| Borrowings | 386 | 1.2k | 864 | 562 | 772 | 1.3k | 1.5k |
| Other Liabilities | 96 | 276 | 365 | 468 | 1.0k | 814 | 875 |
| Total Liabilities | 1.3k | 2.4k | 2.0k | 1.4k | 7.7k | 8.0k | 8.2k |
| AssetsFixed Assets | 633 | 1.2k | 1.4k | 863 | 6.1k | 6.3k | 6.2k |
| CWIP | 431 | 490 | 334 | 188 | 218 | 173 | 314 |
| Investments | 0 | 0 | 4 | 20 | 16 | 20 | 16 |
| Other Assets | 195 | 722 | 314 | 356 | 1.3k | 1.5k | 1.6k |
| Total Assets | 1.3k | 2.4k | 2.0k | 1.4k | 7.7k | 8.0k | 8.2k |
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | -118 | -416 | -163 | -107 | -68 | 9 |
| Cash from Investing | -207 | -692 | -68 | 511 | -201 | -495 |
| Cash from Financing | 381 | 1.2k | 118 | -391 | 412 | 359 |
| SummaryCapital Expenditure | — | — | — | — | — | — |
| Free Cash Flow | -325 | -1.1k | -207 | -171 | -196 | -561 |
| FCF Margin | — | — | — | — | — | — |
For capital-heavy businesses (telecom, power, heavy manufacturing) reported profit ignores the cash needed just to stand still. We'd systematically overvalue it, so we don't show a number.
ONESOURCE · CAPITAL_INTENSIVE
Guides on how to read this kind of business and the numbers that matter.